“…[2] Although recent studies indicate increased role of Acinetobacter infection in mortality in burn patients, some controversy still remains about its exact impact. [3] Due to the increased rate of worldwide resistance and infections, Acinetobacter isolates represent a challenge in the treatment of burns. [4] The data of a total of four hundred and sixty five patients in our burn care unit were reviewed and patients' characteristics and outcome including burn data, infections encountered, pathogens and antibiotic susceptibility tests, infections caused by resistant organisms, risk factors for mortality, and the role of Acinetobacter isolates in mortality were evaluated.…”